# SABRTooth (NCT02629458)

> A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: peripheral stage I non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02629458
- Phase: NA
- Status: COMPLETED
- Sponsor: The Leeds Teaching Hospitals NHS Trust
- Conditions: Oncology
- Interventions: Treatment by Surgical resection; Stereotactic Ablative Radiotherapy (SABR)
- Enrollment: 54
- Primary outcome: Acheivment of a 'steady state' of recruitment.

## Indexed commentary on SABRTooth so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 11 posts on X

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=sabrtooth-nct02629458

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02629458", "email": "<work email>"}; the inbox owner confirms by the emailed link.